Evidence map›Paper›PMID 41196352›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

HIV-1 Vif and Vpr cooperatively modulate the cell cycle to maximize per-cell virion production.

Madison Bandini, Dhaval Ghone, Edward L Evans, Aussie Suzuki, Nathan M Sherer

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Madison BandiniMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, WI 53705.
Dhaval GhoneMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, WI 53705.
Edward L EvansMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, WI 53705.
Aussie SuzukiMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, WI 53705.ORCID 0000-0001-7390-5116
Nathan M ShererMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, WI 53705.ORCID 0000-0001-9974-236X

Funding

Visualizing EBV and HCMV DNA Dynamics During InfectionP01CA022443 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Paul F. Lambert · 1985 to 2026
$53.1M
Center for Structural Biology of HIV RNAU54AI170660 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALICE TELESNITSKY · 2022 to 2026
$32.1M
Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
The Cell Biology of HIV-1 Genome TraffickingR01AI110221 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Nathan M Sherer · 2014 to 2026
$4.4M
Chromosome dynamics and organizations necessary for faithful chromosome segregationR35GM147525 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Aussie Suzuki · 2022 to 2026
$2.5M
The Cell Biology of HIV-1 Genome TraffickingR56AI110221 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SHERER, NATHAN M · 2024 to 2024
$457k
HHS | NIH (NIH) P01CA022443HHS | NIH (NIH) R01AI110221HHS | NIH (NIH) R35GM147525HHS | NIH (NIH) T32CA009135HHS | NIH (NIH) U54AI170660NCI NIH HHS P01 CA022443NCI NIH HHS T32 CA009135NIAID NIH HHS R01 AI110221NIAID NIH HHS R56 AI110221NIAID NIH HHS U54 AI170660NIGMS NIH HHS R35 GM147525Wisconsin Alumni Research Foundation (WARF) Research Forward
6 · The paper itself

Abstract

The HIV type 1 (HIV-1) accessory proteins Virion Infectivity Factor (Vif) and Viral Protein R (Vpr) are essential for efficient virus replication in vivo. Vif mediates degradation of host restriction factor APOBEC3G, while Vpr modulates the host cell proteome in ways that promote virion infectivity and viral gene expression. In cycling cells including CD4+ T cells, Vif and Vpr also severely impact cell cycle progression for reasons that remain unknown. Here, we combined live-cell imaging with virological assays to define the relative impacts of Vif and Vpr on the cell cycle and single-cell virion production. We demonstrate that Vif and Vpr's effects on the cell cycle are markedly distinct, with Vif arresting cells in mitosis, while Vpr causes a G2 phase delay followed by endoreplication and reversion of cells into a "pseudo-G1" cell state lacking G2 markers. When coexpressed, Vpr's capacity to bypass mitosis acts to suppress cytotoxicity associated with Vif-mediated cell cycle arrest, with the two proteins cooperating to extend the infected cell's time in interphase as much as fivefold. Vpr-driven endoreplication also caused duplication of transcriptionally active proviral genomes, yielding a correlative ~twofold increase in per-cell viral gene expression. Based on these findings, we propose that Vif and Vpr coordinately regulate the cell cycle to prolong the infected cell's lifespan and maximize single-cell virion output.

Indexed as

Cell CycleHIV-1vif Gene Products, Human Immunodeficiency VirusVirionvpr Gene Products, Human Immunodeficiency VirusCD4-Positive T-LymphocytesHEK293 CellsHumansVirus Replicationvif Gene Products, Human Immunodeficiency Virusvif protein, Human immunodeficiency virus 1vpr Gene Products, Human Immunodeficiency Virusvpr protein, Human immunodeficiency virus 1cell cycleHIVVifviral replicationVpr

Identifiers

PMID41196352
PMCPMC12626010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.